Cizumab 400mg Bevacizumab Injection

Cizumab 400mg Bevacizumab Injection is a prescription targeted anti-cancer medication used in the treatment of various cancers, including colorectal cancer, non-small cell lung cancer, kidney cancer, ovarian cancer, and cervical cancer. It contains Bevacizumab, a monoclonal antibody that works by blocking vascular endothelial growth factor (VEGF), a protein that promotes the formation of new blood vessels needed for tumor growth and survival. By inhibiting this process, Cizumab 400mg Bevacizumab Injection helps slow tumor progression and reduce the spread of cancer cells. Administered as an intravenous infusion under the supervision of an oncology specialist, it is often used in combination with chemotherapy or other cancer therapies. Regular monitoring during treatment is important to evaluate effectiveness and manage potential side effects. Patients should use Cizumab 400mg Bevacizumab Injection only as prescribed by their healthcare provider.